“The reality is, when you’re optimizing for production, you start looking at a price/performance,” Guillermo Rauch tells TechCrunch.
One Place News
- Technology & AI
- July 11, 2026
- 5 views
Reed Jobs would rather talk about curing cancer than his last name
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now,…
